Molecular characterization of FXI deficiency

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 1, 2011, Pages 27-32

  Berber, Ergul ^a  

^a HALIC UNIVERSITY   (Turkey)

Author keywords

bleeding; blood coagulation factors; gene polymorphisms; hemostasis

Indexed keywords

BLOOD CLOTTING FACTOR 11;

ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CROSS REACTION; DATA BASE; DNA POLYMORPHISM; GENE; GENE MUTATION; GENETIC ASSOCIATION; HEMOSTASIS; HUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; DATABASES, GENETIC; FACTOR XI; FACTOR XI DEFICIENCY; HEMORRHAGE; HUMANS; PREVALENCE; PROTEIN STRUCTURE, TERTIARY;

EID: 78651412365     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609355587     Document Type: Article

References (59)

1. Davie E., Fujikawa W. The coagulation cascade initiation, maintenance and regulation. Biochemistry. 1991 ; 30 (43). 10363-10370.
2. Gailani D., Broze GJ. Factor XI activation in a revised model of blood coagulation. Science. 1991 ; 253 (5022). 909-912.
3. Shpilberg O., Peretz H., Zivelin A., et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood. 1995 ; 85 (2). 429-432.
4. Ragni MV, Sinha D., Seaman F., Lewis JH, Spero JA, Walsh PN Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood. 1985 ; 65 (3). 719-724.
5. Bolton-Maggs PH, Young Wan - Yin B., McCraw AH, Slack J., Kerrnoff PB Inheritance and bleeding in factor XI deficiency. Br J Haematol. 1988 ; 69 (4). 521-528.
6. Bouma BN, Meijers JC Role of blood coagulation factor XI in down regulation of fibrinolysis. Curr Opin Hemetol. 2000 ; 7 (5). 266-272.
7. Mannucci PM, Duga S., Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004 ; 104 (5). 1243-1252.
8. Gomez K., Bolton-Maggs P. Factor XI deficiency. Haemophilia. 2008 ; 14 (6). 1183-1189.
9. Asakai R., Davie EW, Chung DW Organization of the gene for human factor XI. Biochemistry. 1987 ; 26 (23). 7221-7228.
10. Kato A., Asakai R., Davie EW, Aoki N. Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4. Cytogenet Cell Genet. 1989 ; 52 (1-2). 77-78.
11. Tarumi T., Kravtsov DV, Zhao M., Williams SM, Gailani D. Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha) is required for hepatocyte-specific expression of factor XI. J Biol Chem. 2002 ; 277 (21). 18510-18516.
12. Tarumi T., Kravtsov DV, Moore JH, Williams SM, Galiani D. Common single nucleotide polymorphisms in the promoter region of the human factor XI gene. J Thromb Haemost. 2003 ; 1 (8). 1854-1856.
13. Podmore A., Smith M., Savidge G., Alhaq A. Real-time quantitative PCR analysis of factor XI mrnavariants in human platelets. J Thromb Haemost. 2004 ; 2 (10). 1713-1719.
14. Hsu TC, Shore SK, Seshsmma T., Bagasra O., Walsh PN. Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene. J Biol Chem. 1998 ; 273 (22). 13787-13793.
15. Martincic D., Kravtsov DV, Gailani D. Factor XI messenger RNA in human platelets. Blood. 1999 ; 94 (10). 3397-3404.
16. Cheng Q., Kante J., Poffenberger G., Powers AC, Gailani D. Factor XI protein in human pancreas and kidney. Thromb Haemost. 2008 ; 100 (1). 158-160.
17. Wu W., Sinha D., Shikov S., et al. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin and factor XIa. J Biol Chem. 2008 ; 283 (27). 18655-18664.
18. Fujikawa K., Chang DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry. 1986 ; 25 (9). 2417-2424.
19. McMullen BA, Fujikawa K., Davie EW Location of the disulfide bonds in human coagulation factor XI: the presence of tandem repeats. Biochemistry. 1991 ; 30 (8). 2056-2060.
20. Chung DW, Fujikawa K., McMullen BA, Davie EW Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry. 1986 ; 25 (9). 2410-2417.
21. Meijers JC, Davie EW, Chung DW Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood. 1992 ; 79 (6). 1435-1440.
22. Renne T., Sugiyama A., Gailani D., Jahnen-Dechent W., Walter U., Muller-Esterl W. Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2. Int Immunopharmacol. 2002 ; 2 (13-14). 1867-1873.
23. Sun Y., Gailani D. Identification of a factor IX binding site on the third apple domain of activated factor XI. J Biol Chem. 1996 ; 271 (46). 29023-29028.
24. Baglia FA, Jameson BA, Walsh PN Identification and characterization of a binding site for platelets in the Apple 3 domain of coagulation factor XI. J Biol Chem. 1995 ; 270 (12). 6734-6740.
25. O'Connell NM Factor XI deficiency-from molecular genetics to clinical management. Blood Coagul Fibrinolysis. 2003 ; 14 (suppl 1). S59 - S64.
26. McMullen BA, Fujikawa K., Davie EW Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry. 1991 ; 30 (8). 2050-2056.
27. Sinha D., Marcinkiewicz M., Gailani D., Walsh PN Molecular cloning and biochemical characterization of rabbit factor XI. Bichem J. 2002 ; 367 (pt 1). 49-56.
28. Zucker M., Zivelin A., Landau M., Rosenberg N., Seligsohn U. Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI. J Thromb Haemost. 2009 ; 7 (6). 970-975.
29. McVey JH, Lal K., Imanaka Y., Kemball-Cook G., Bolton-Maggs PH, Tuddenham EG Characterisation of blood coagulation factor XI T495I. Thromb Haemost. 2005 ; 93 (6). 1082-1088.
30. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of FXII. Arterioscler Thromb Vasc Biol. 1999 ; 19 (1). 170-177.
31. Ho DH, Badellino K., Baglia FA, Sun MF, Zhao MM, Gailani D., Walsh PN The role of high molecular weight kininogen and pro-thrombin as cofactors in the binding of factor XI A3 domain to the platelet surface. J Biol Chem. 2000 ; 275 (33). 25139-25145.
32. Guella G., Solda G., Spena S., et al. Molecular characterization of two novel mutations causing factor XI deficiency: a splicing defect and a missense mutation responsible for a CRM+ defect. Thromb Haemost. 2008 ; 99 (3). 523-530.
33. Navaneetham D., Jin L., Pandev P., Strickler JE, Babine RE, Abdel-Mequid SS, Walsh PN Structural and mutational analyses of the molecular interactions between the catalytic domain of factor xia and the Kunitz protease inhibitor domain of protease nexin 2. J Biol Chem. 2005 ; 280 (43). 36165-36175.
34. von dem Borne PAKr, Joost CM, Bouma BN Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood. 1995 ; 86 (8). 3035-3042.
35. von dem Borne PAKr, Bajzar L., Meijers JCM, Nesheim ME, Bouma BN Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest. 1997 ; 99 (10). 2323-2327.
36. Kadir RA, Kingman CE, Chi C., et al. Screening for factor XI deficiency amongst women of Ashkenazi Jewish origin. Haemophilia. 2006 ; 12 (6). 625-628.
37. Meijers JC, Middeldrop S., Tekelenburg W., et al. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of tw low-dose oral contraceptives. Thromb Haemost. 2000 ; 84 (1). 9-14.
38. Wang X., Smith PL, Hsu MY, et al. Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice. J Thromb Haemost. 2006 ; 4 (9). 1982-1988.
39. Salomon O., Steinberg DM, Koren-Morag N., Tanne D., Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood. 2008 ; 111 (8). 4113-4117.
40. Salomon O., Steinberg DM, Dardik R., et al. Inherited Factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost. 2003 ; 1 (4). 658-661.
41. Zadra G., Asselta R., Malcovati M., et al. Molecular genetic analysis of severe coagulation factor XI in six Italian patients. Haematologica. 2004 ; 89 (11). 1332-1340.
42. Zucker M., Zivelin A., Teitel J., Seligsohn U. Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by RH immune globulin. Blood. 2008 ; 111 (3). 1306-1308.
43. Salomon O., Zivelin A., Livnat T., et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood. 2003 ; 101 (12). 4783-4788.
44. Tavori S., Brenner B., Tatarsky I. The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis. Thromb Haemost. 1990 ; 63 (1). 36-38.
45. Asakai R., Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorders that can result from three types of point mutations. Proc Natl Acad Sci U S A. 1989 ; 86 (20). 7667-7671.
46. Peretz H., Zivelin A., Usher S., Seligsohn U. A 14-bp deletion (codon 554 delaaggtaacagagtg) at exon 14/intron Njunction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Human Mutat. 1996 ; 8 (1). 77-78.
47. Zivelin A., Bauduer F., Ducout L., et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood. 2002 ; 99 (7). 2448-2454.
48. Quelin F., Trossaert M., Sigaud M., Mazancourt PD, Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost. 2004 ; 2 (1). 71-76.
49. Bolton-Maggs PH, Peretz H., Butler R., et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost. 2004 ; 2 (6). 918-924.
50. Mitchell MJ, Dai L., Clarke JB, Bolton-Maggs PHB, Savidge GF, Alhaq A. Characterisation of five factor XI mutations. Thromb Haemost. 2007 ; 97 (6). 884-889.
51. Zucker M., Zivelin A., Landau M., et al. Characterization of seven novel muatations causing factor XI deficiency. Haematologica. 2007 ; 92 (10). 1375-1380.
52. Solda G., Asselta R., Ghiotto R., Tenchini ML, Castaman G., Duga S. A type II mutation (Glu117Stop), induction of allele-specific mRNA degradation and factor XI deficiency. Haematologica. 2005 ; 90 (12). 1716-1718.
53. Kravtsov DV, Wu W., Meijers JC, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood. 2004 ; 104 (1). 128-134.
54. Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood. 2005 ; 105 (12). 4671-4673.
55. Sun MF, Baglia FA, Martincic D., Ware RE, Walsh PN, Gailani D. Defective binding of factor XI-N248 to activated human platelets. Blood. 2001 ; 98 (1). 125-129.
56. Pugh RE, McVey JH, Tuddenham EGD, Hancock JF Six point mutations that cause Factor XI deficiency. Blood. 1995 ; 85 (6). 1509-1516.
57. Bozzao C., Rimoldi V., Asselta R., et al. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency. FEBS J. 2007 ; 274 (23). 6128-6138.
58. Gailani D., Schmidt A., Sun MF, Bolton-Maggs PH, Bajaj SP A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect. J Thromb Haemost. 2007 ; 5 (4). 781-787.
59. Zivelin A., Ogawa T., Bulvik S., et al. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation. J Thromb Haemost. 2004 ; 2 (10). 1782-1789.